New Results
A comprehensive library of canonical and non-canonical MHC class I antigens for cancer vaccine development
View ORCID ProfileGeorges Bedran, Tongjie Wang, Dominika Pankanin, Kenneth Weke, Alexander Laird, Christophe Battail, Fabio Massimo Zanzotto, Catia Pesquita, Håkan Axelson, Ajitha Rajan, David J. Harrison, Aleksander Palkowski, Maciej Pawlik, Maciej Parys, Robert O’Neill, Paul M. Brennan, Stefan Symeonides, David R. Goodlett, Kevin Litchfield, Robin Fahraeus, Ted R. Hupp, Sachin Kote, View ORCID ProfileJavier A. Alfaro
doi: https://doi.org/10.1101/2022.01.13.475872
Georges Bedran
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
Tongjie Wang
2School of Informatics, University of Edinburgh, Edinburgh, UK
Dominika Pankanin
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
Kenneth Weke
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
Alexander Laird
3Urology Department, Western General Hospital, NHS Lothian, Edinburgh, UK
4Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
Christophe Battail
5CEA, Université Grenoble Alpes, INSERM, IRIG, Laboratoire Biosanté UMR1292, Grenoble, France
Fabio Massimo Zanzotto
6Department of Enterprise Engineering, University of Rome “Tor Vergata”, Rome, Italy
Catia Pesquita
7LASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal
Håkan Axelson
8Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden
Ajitha Rajan
2School of Informatics, University of Edinburgh, Edinburgh, UK
David J. Harrison
9School of Medicine, University of St Andrews, St Andrews, UK
Aleksander Palkowski
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
Maciej Pawlik
10Academic Computer Centre CYFRONET, AGH University of Science and Technology, Cracow, Poland
Maciej Parys
11Royal (Dick) School of Veterinary Studies and The Roslin Institute, University of Edinburgh, Edinburgh, UK
Robert O’Neill
12Cambridge Oesophagogastric Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Paul M. Brennan
13Translational Neurosurgery, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
Stefan Symeonides
4Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
David R. Goodlett
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
14Department of Biochemistry and Microbiology, University of Victoria, Victoria, Canada
15University of Victoria Genome BC Proteome Centre, Victoria, Canada
Kevin Litchfield
16Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
17Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK
Robin Fahraeus
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
18Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Paris, France
Ted R. Hupp
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
4Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
Sachin Kote
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
Javier A. Alfaro
1International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
Posted January 20, 2022.
A comprehensive library of canonical and non-canonical MHC class I antigens for cancer vaccine development
Georges Bedran, Tongjie Wang, Dominika Pankanin, Kenneth Weke, Alexander Laird, Christophe Battail, Fabio Massimo Zanzotto, Catia Pesquita, Håkan Axelson, Ajitha Rajan, David J. Harrison, Aleksander Palkowski, Maciej Pawlik, Maciej Parys, Robert O’Neill, Paul M. Brennan, Stefan Symeonides, David R. Goodlett, Kevin Litchfield, Robin Fahraeus, Ted R. Hupp, Sachin Kote, Javier A. Alfaro
bioRxiv 2022.01.13.475872; doi: https://doi.org/10.1101/2022.01.13.475872
A comprehensive library of canonical and non-canonical MHC class I antigens for cancer vaccine development
Georges Bedran, Tongjie Wang, Dominika Pankanin, Kenneth Weke, Alexander Laird, Christophe Battail, Fabio Massimo Zanzotto, Catia Pesquita, Håkan Axelson, Ajitha Rajan, David J. Harrison, Aleksander Palkowski, Maciej Pawlik, Maciej Parys, Robert O’Neill, Paul M. Brennan, Stefan Symeonides, David R. Goodlett, Kevin Litchfield, Robin Fahraeus, Ted R. Hupp, Sachin Kote, Javier A. Alfaro
bioRxiv 2022.01.13.475872; doi: https://doi.org/10.1101/2022.01.13.475872
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)